Lipid-derivatized bisphosphonic acid
    1.
    发明授权
    Lipid-derivatized bisphosphonic acid 有权
    脂质衍生的双膦酸

    公开(公告)号:US07455856B2

    公开(公告)日:2008-11-25

    申请号:US10597059

    申请日:2005-01-24

    IPC分类号: A61K9/127

    摘要: A bisphosphonic acid of the general formula (I) wherein R1 is H, OH, C1-C6 alkyl C1-C6 alkoxy, C1-C6 hydroxyalkyl, C1-C6 aminoalkyl, C1-C6 halogen alkyl X is a direct bond, alkylen group with 1 to 20 carbon atoms, (CH3)m—(OCR3HCH2)n—(O)o—, wherein R3 is H or CH3 and m is 0 or a number from 1 to 6, n is a number from 1 to 10, preferably 1 to 6, and o is 0 or 1, —(CR4HCH2O)p—, wherein R4 is H or CH3, p is a number from 1 to 10, preferably 1 to 6, (CH3)q—(OCR5HCH2)r—(O)s—(CH3)t—, wherein R5 is H or CH3 and q is 0 or a number from 1 to 6, r is a number from 1 to 10, preferably 1 to 6, and s is 0 or 1, and t is a number from 1 to 6, R2 is a group of the formula (II) as well as their physiologically compatible derivatives in particular salts and trimethyl silyl derivatives.

    摘要翻译: 通式(I)的二膦酸,其中R 1是H,OH,C 1 -C 6烷基C 1 C 6 -C 6烷氧基,C 1 -C 6羟烷基,C 1 -C 3 > 6个氨基烷基,C 1 -C 6卤代烷基X是直接键,具有1至20个碳原子的亚烷基(CH 3) (OCR 3)HCH 2 O 2 - (O)O 其中R 3为H或CH 3,m为0或1至6的数,n为1至10的数,优选为 1至6,且o为0或1, - (CR 4 HCH 2 O)p - ,其中R 4, / CH 2是H或CH 3,p是1至10,优选1至6的数,(CH 3 3)q - (OCR 5 HCH 2) - (O)S - (CH 3)3 其中R 5为H或CH 3,q为0或数1至6,r为数 1〜10,优选1〜6,s为0或1,t为数 m 1至6,R 2是式(II)的基团以及它们的生理上相容的衍生物,特别是盐和三甲基甲硅烷基衍生物。

    Lipid-derivatized bisphosphonic acid
    2.
    发明申请
    Lipid-derivatized bisphosphonic acid 有权
    脂质衍生的双膦酸

    公开(公告)号:US20070154537A1

    公开(公告)日:2007-07-05

    申请号:US10597059

    申请日:2005-01-24

    摘要: A bisphosphonic acid of the general formula (I) wherein R1 is H, OH, C1-C6 alkyl C1-C6 alkoxy, C1-C6 hydroxyalkyl, C1-C6 aminoalkyl, C1-C6 halogen alkyl X is a direct bond, alkylen group with 1 to 20 carbon atoms, (CH3)m—(OCR3HCH2)n—(O)o— wherein R3 is H or CH3 and m is 0 or a number from 1 to 6, n is a number from 1 to 10, preferably 1 to 6, and o is 0 or 1,  —(CR4HCH2O)p— wherein R4 is H or CH3, p is a number from 1 to 10, preferably 1 to 6,  (CH3)q—(OCR5HCH2)r—(O)s—(CH3)t—, wherein R5 is H or CH3 and q is 0 or a number from 1 to 6, r is a number from 1 to 10, preferably 1 to 6, and s is 0 or 1, and t is a number from 1 to 6, R2 is a group of the formula (II) as well as their physiologically compatible derivatives, in particular salts and trimethyl silyl derivatives.

    摘要翻译: 通式(I)的二膦酸,其中R 1是H,OH,C 1 -C 6烷基C 1 C 6 -C 6烷氧基,C 1 -C 6羟烷基,C 1 -C 3 > 6个氨基烷基,C 1 -C 6卤代烷基X是直接键,具有1至20个碳原子的亚烷基(CH 3) (OCR 3)HCH 2 O 2 - (O)O 其中R 3为H或CH 3,m为0或1至6的数,n为1至10的数,优选1 至6,o为0或1, - (CR 4 HCH 2 O)p - 其中R 4 = >是H或CH 3,p是1至10的数,优选1至6,(CH 3 3)q - (OCR (O 3) - (CH 3)3 - (O) - (CH 3) 其中R 5是H或CH 3,q是0或1-6的数,r是1的数 至10,优选1至6,s为0或1,t为数 1至6,R 2是式(II)的基团以及它们的生理上相容的衍生物,特别是盐和三甲基甲硅烷基衍生物。